UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?

Leal, P; Stein, K; Rosenberg, W; (1999) What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users? J Med Screen , 6 (3) 124 - 131.

Full text not available from this repository.

Abstract

To model the likely cost utility of the prevalence round of a screening programme for hepatitis C (HCV) in intravenous drug users (IVDUs) in contact with services in the South and West health region of the UK.

Type: Article
Title: What is the cost utility of screening for hepatitis C virus (HCV) in intravenous drug users?
Location: ENGLAND
Language: English
Keywords: Comorbidity, Cost-Benefit Analysis, Enzyme-Linked Immunosorbent Assay, Hepacivirus, Hepatitis C, Humans, Interferon-alpha, Mass Screening, Polymerase Chain Reaction, Prevalence, Sensitivity and Specificity, Substance Abuse, Intravenous
URI: http://discovery.ucl.ac.uk/id/eprint/1340667
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item